Stocks and Investing
Stocks and Investing
Mon, November 29, 2021
Fri, November 26, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 24, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (AADI) at Strong Buy with Increased Target to $735 on, Nov 24th, 2021
Robert Burns of HC Wainwright & Co., Maintained "Aadi Bioscience, Inc." (AADI) at Strong Buy with Increased Target from $705 to $735 on, Nov 24th, 2021.
Robert has made no other calls on AADI in the last 4 months.
There are 2 other peers that have a rating on AADI. Out of the 2 peers that are also analyzing AADI, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- Boris Peaker of "Cowen & Co." Initiated at Buy on, Friday, October 1st, 2021
- Joseph Catanzaro of "Piper Sandler" Initiated at Buy and Held Target at $675 on, Wednesday, September 8th, 2021
Contributing Sources